UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16198

2023

Link zum Volltext

Verfügbarkeit prüfen

Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis

Breast cancer research : BCR, 2019-09, Vol.21 (1), p.107-107, Article 107

2019

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond

Cancers, 2022-09, Vol.14 (17), p.4332

2022

Link zum Volltext

Verfügbarkeit prüfen

Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci

Nature communications, 2024-05, Vol.15 (1), p.4319-4319, Article 4319

2024

Link zum Volltext

Verfügbarkeit prüfen

Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry

Nature communications, 2024-04, Vol.15 (1), p.3220-3220, Article 3220

2024

Link zum Volltext

Verfügbarkeit prüfen

Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature

Respiratory medicine case reports, 2019-01, Vol.27, p.100834, Article 100834

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer

Biomedicines, 2023-05, Vol.11 (5), p.1470

2023

Link zum Volltext

Verfügbarkeit prüfen

Cancer complaints: The profile of patients from the emergency department of a Brazilian oncology teaching hospital [version 1; peer review: 2 approved]

F1000 research, 2017, Vol.6, p.1919-1919

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Letter

Clinical cancer research, 2023-03, Vol.29 (6), p.1157-1157

2023

Link zum Volltext

Verfügbarkeit prüfen

Off-Pump Triple Coronary Artery Bypass Grafting in a Patient with Situs Inversus Totalis: Case Presentation and a Brief Review of the Brazilian and the International Experiences

Revista brasileira de cirurgia cardiovascular, 2016-04, Vol.31 (2), p.198-202

2016

Link zum Volltext

Verfügbarkeit prüfen

Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk‐based testing of those older than 60 years

Cancer, 2021-03, Vol.127 (6), p.828-833

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of homologous recombination deficiency biomarkers in patients with ovarian cancer treated with PARP inhibitors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17615-e17615

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and serum estradiol levels in hormonal treatments for vulvovaginal atrophy in breast cancer survivors: A systematic review and meta-analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24049-e24049

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of KMT2C loss-of-function mutations in circulating tumor DNA and prolonged response to the combination of PARPi and PI3Ki

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13003-e13003

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

Clinical cancer research, 2022-04, Vol.28 (8), p.1493-1499

2022

Link zum Volltext

Verfügbarkeit prüfen

Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

Cancer treatment reviews, 2022-07, Vol.108, p.102410-102410, Article 102410

2022

Link zum Volltext

Verfügbarkeit prüfen

An overview of artificial intelligence in oncology

Future science OA, 2022-04, Vol.8 (4), p.FSO787-FSO787

2022

Link zum Volltext

Verfügbarkeit prüfen

Penetrating cardiac trauma by firearm: better outcomes and importance of prehospital care system

Journal of the Pakistan Medical Association, 2015-09, Vol.65 (9), p.1032-1032

2015

Link zum Volltext

Verfügbarkeit prüfen

Response in BRCA1 mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX

BMJ case reports, 2022-04, Vol.15 (4), p.e249370

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3531-3531

2023

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with colorectal cancer (CRC) with low expression of homologous recombination proficient (HRP) genes

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.225-225

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 156: Mutational signature 3 predicts responses to olaparib plus buparlisib in triple-negative breast cancer and high-grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.156-156

2021

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors for Breast Cancer: Germline IBRCA1/2/I and Beyond

Cancers, 2022-09, Vol.14 (17)

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Clinical cancer research, 2022-11, Vol.28 (21), p.4714-4723

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of real-world (RW) data for metastatic breast cancer (mBC) patients (pts) with somatic BRCA1/2 ( sBRCA ) or other homologous recombination (HR)-pathway gene mutations (muts) treated with PARP inhibitors (PARPi)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10512-10512

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(43)
Portugiesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches

Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis

PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond

Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci

Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry

Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer

Cancer complaints: The profile of patients from the emergency department of a Brazilian oncology teaching hospital [version 1; peer review: 2 approved]

Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Letter

Off-Pump Triple Coronary Artery Bypass Grafting in a Patient with Situs Inversus Totalis: Case Presentation and a Brief Review of the Brazilian and the International Experiences

Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk‐based testing of those older than 60 years

Evaluation of homologous recombination deficiency biomarkers in patients with ovarian cancer treated with PARP inhibitors

Safety and serum estradiol levels in hormonal treatments for vulvovaginal atrophy in breast cancer survivors: A systematic review and meta-analysis

Association of KMT2C loss-of-function mutations in circulating tumor DNA and prolonged response to the combination of PARPi and PI3Ki

Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer

Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

An overview of artificial intelligence in oncology

Penetrating cardiac trauma by firearm: better outcomes and importance of prehospital care system

Response in BRCA1 mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX

Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes

Survival of patients with colorectal cancer (CRC) with low expression of homologous recombination proficient (HRP) genes

Abstract 156: Mutational signature 3 predicts responses to olaparib plus buparlisib in triple-negative breast cancer and high-grade serous ovarian cancer

PARP Inhibitors for Breast Cancer: Germline IBRCA1/2/I and Beyond

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Analysis of real-world (RW) data for metastatic breast cancer (mBC) patients (pts) with somatic BRCA1/2 ( sBRCA ) or other homologous recombination (HR)-pathway gene mutations (muts) treated with PARP inhibitors (PARPi)

Suchergebnisse filtern